Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px
Organisation › Details

PolyPeptide (Group)

PolyPeptide Group AG with its consolidated subsidiaries (“PolyPeptide”) is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world. PolyPeptide offers products and services from pre-clinical through to commercial stages, including generics. Its active custom projects pipeline reflects the opportunities from novel drug therapies in development to fight both widespread and rare diseases. Dating back to 1952, PolyPeptide today runs a global network of six cGMP-certified facilities in Europe, the U.S. and India. PolyPeptide’s shares (SIX: PPGN) are listed on SIX Swiss Exchange. *


Period Start 2023-05-09 existent
Products Industry peptide synthesis
  Industry 2 contract manufacturing (biologicals)
Region Region Baar ZG
  Country Switzerland
  Street 24 Neuhofstr.
  City 6340 Baar ZG
  Tel +41-43-502-0580
    Address record changed: 2023-05-11
Basic data Employees F: 1,001 to 5,000 (2023-05-10)
  Currency CHF
  Annual sales 9,960,000 (income, total, consolidated (2022) 2022-12-31)
  Profit -1,163,631,000 (2022-12-31)
  Cash 10,061,000 (2022-12-31)
    * Document for »About Section«: Numaferm GmbH. (5/9/23). "Press Release: PolyPeptide and Numaferm Announce Partnership to Leverage Their Expertise for the More Sustainable Production of Peptide-based APIs". Baar & Düsseldorf.
Record changed: 2023-07-10


Picture EBD Group World of Partnering Opportunities 650x200px

More documents for PolyPeptide (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Stier Group MIXiii Lifescience Healthtech Conference 650x300px

» top